- RESEARCH HIGHLIGHT
A non-covalent inhibitor with pan-KRAS potential
Access options
Nature Reviews Drug Discovery 22, 622 (2023)
doi: https://doi.org/10.1038/d41573-023-00115-8
References
Kim, D. et al. Pan-KRAS inhibitor disables oncogenic signalling and tumour growth. Nature 619, 160–166 (2023)